Citation Impact
Citing Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
2000 Standout
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study
2010
Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome.
1993 StandoutNobel
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Antibody specificity and immunoglobulin VH utilization of human monoclonal CD5+ B cell lines
1991
Autoimmune Complications of Chronic Lymphocytic Leukemia
2006
A view on drug resistance in cancer
2019 StandoutNature
Breast cancer
2016 Standout
Chronic myelogenous leukemia in nonlymphoid blastic phase
1999
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status
2005
Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium
1988
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.
1990
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer
2002
Focus on bladder cancer
2004
Lymphoid Malignancies: the dark side of B-cell differentiation
2002
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.
1989
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
2013
Gemcitabine in transitional cell carcinoma of the urothelium
2003
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
1989 StandoutNature
The CD5 B Cell
1989
Bladder cancer: Long-term follow-up results of patients treated with radical radiation
1991
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen
2006
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Molecular cloning of a human immunoglobulin heavy chain variable (V ) region with anti-myelin-associated glycoprotein activity
1990
Phase II study ofcis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract
1992
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
Bladder cancer
2016 Standout
Immunity, Inflammation, and Cancer
2010 Standout
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
1992
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
2005
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
1997
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.
1992 StandoutNobel
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Recent developments in the field of antitumour anthracyclines
2001
The role of antisense oligonucleotides in the treatment of bladder cancer
2002
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
B cells of chronic lymphatic leukemia express V genes in unmutated form
1991
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
2001
MicroRNA signatures in human cancers
2006 Standout
Role of gemcitabine in cancer therapy
2005
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias
1990
The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loops
1992 StandoutNobel
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial
1999
Structural repertoire of the human VH segments
1992 StandoutNobel
Liposomal cisplatin: a new cisplatin formulation
2010
From Human Autoantibodies to the Fetal Antibody Repertoire to B Cell Malignancy: It's a Small World After All
1990
The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire
1994
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
CD5 B Cells, a Fetal B Cell Lineage
1993
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer
1991
Chronic Lymphocytic Leukemia
2005
Autoimmunity-Prone B-L (Cd5 B) Cells, Natural Antibodies and Self Recognition
1993
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Integrated Therapy for Locally Advanced Bladder Cancer: Final Report of a Randomized Trial of Cystectomy Plus Adjuvant M-VAC Versus Cystectomy With Both Preoperative and Postoperative M-VAC
2001
METASTATIC BLADDER CANCER
1992
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
2000
Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
2009
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Plasmacytoid Carcinoma of the Bladder: A Urothelial Carcinoma Variant With a Predilection for Intraperitoneal Spread
2012
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Bladder Cancer
2020 Standout
Amplification and Rearrangement of Hu- ets -1 in Leukemia and Lymphoma with Involvement of 11q23
1986 Science
Cytotoxic effect of a polymer–copper(II) complex containing 2,2′-bipyridyl ligand on human lung cancer cells
2010
The Rationale for EN Bloc Pelvic Lymph Node Dissection for Bladder Cancer Patients with Nodal Metastases: Long-Term Results
1993
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases
1985
Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production
2002
Migration and Differentiation of Autoreactive B-1 Cells Induced by Activated γ/δ T Cells in Antierythrocyte Immunoglobulin Transgenic Mice
2000 StandoutNobel
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
Gemcitabine Plus Cisplatin, an Active Regimen in Advanced Urothelial Cancer: A Phase II Trial of the National Cancer Institute of Canada Clinical Trials Group
1999
Gene Expression Profiling of Lymphoid Malignancies
2002
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
1996
Paclitaxel in Advanced Urothelial Carcinoma: Its Role in Patients with Renal Insufficiency and as Salvage Therapy
1996
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
2005
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
1998
T-Independent Immune Response: New Aspects of B Cell Biology
2000 StandoutScienceNobel
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
2014
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather
1999
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
2001
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
2011
Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Metastatic Urothelial Cancer
2000
Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus.
1991
Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy
1999
The Role of Adjuvant Chemotherapy Following Cystectomy for Invasive Bladder Cancer: A Prospective Comparative Trial
1991
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
2005 Standout
Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
2014
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
1995
Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 Cases
1997
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Evidence for a multistep pathogenesis of a myelodysplastic syndrome
1984
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone
2003
Works of Lora Weiselberg being referenced
Cis-platinum chemotherapy for ocular basal cell carcinoma.
1991
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse
1989
Use of Cisplatin for Elderly Patients
1992
Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium
1985
Acquired idiopathic sideroblastic anemia: A new chromosomal abnormality
1983
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.
1988
5-Year Results of Dose-Intensive Sequential Adjuvant Chemotherapy for Women With High-Risk Node-Positive Breast Cancer: A Phase II Study
1999
Dysmyelopoietic syndrome
1984
M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium
1988
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
1989